About the Partner
npj Genomic Medicine is published by Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University.
The Center of Excellence in Genomic Medicine Research (CEGMR) is based at King Abdulaziz University in Jeddah, Kingdom of Saudi Arabia (KSA) and was founded in March, 2007 by its current Director, Prof. Mohammed Al-Qahtani. The main aim of the CEGMR is to conduct basic and applied medical research to the highest international standards using cutting-edge facilities to study genetic disorders that are common in the KSA to address important health issues at the genomic, proteomic and epigenetic scale. Research programs at CEGMR include cancer genomics, functional and developmental genomics, neurogenomics, pharmacogenomics, genomic screening of complex disorders, stem cells & regenerative medicine and biorepositories & biospecimen. CEGMR is striving through its research programs to unravel the genetic variability of diseases aiming to discover novel therapies to address unmet medical needs.
King Abdulaziz University (KAU) was established in 1967 in Jeddah, Saudi Arabia as a national university aimed at spreading higher education in the western province of Saudi Arabia. In 1974 King Abdulaziz University was converted to a public university by a resolution of the Council Ministers of the Kingdom of Saudi Arabia. The government's adoption and continuous support for this young university has had a great effect on transforming KAU into a modern university. The university occupies a distinguished place among higher education institutions in the KSA. KAU has more than 4,500 PhD-holding staff and around 46,000 students from 60 different countries, and its research productivity and knowledge-transfer output play a vital role in society. It has 16 centers of research excellence, 24 scientific chairs and a research endowment.